NanoViricides prices offering with 2,516,339 warrants at US$ 1.75 exercise price
NNVC•Offering priced with common shares or pre-funded warrants and full warrants
NanoViricides priced a registered direct offering of 2,516,339 common shares or pre-funded warrants, with full warrants for 2,516,339 shares.
The warrants carry an exercise price of US$ 1.75 per share and expire 5.5 years from issuance.
Gross proceeds are expected to be about US$ 3.8 million, and closing is targeted for about July 27, 2026.
